Michael S Hearne
CIK 1759910 · Chief Financial Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.84M
Companies
3
Total Filings
107
Lifetime Open-Market Net
$12.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AUPH | Chief Financial Officer | 116,144 | $15.82 | $1.84M | $0 | 1 | 2026-05-20 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Financial Officer | 9,618,120 | $6.22 | $59.82M | $0 | 45 | 2022-07-05 |
| Odonate Therapeutics, Inc. (ODT) Delisted | Chief Financial Officer | 15,517,186 | $1.12 | $17.38M | $12.78M | 59 | 2021-03-17 |
Recent Filings · Page 8 of 11
107 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-04 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +47 | $1.1K | EDGAR |
| 2020-04-17 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +50 | $1.1K | EDGAR |
| 2020-04-02 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +24 | $563 | EDGAR |
| 2020-03-17 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +29 | $568 | EDGAR |
| 2020-03-03 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +22 | $553 | EDGAR |
| 2020-02-19 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +21 | $561 | EDGAR |
| 2020-02-04 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +23 | $571 | EDGAR |
| 2020-01-17 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +24 | $556 | EDGAR |
| 2020-01-03 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +20 | $552 | EDGAR |
| 2019-12-17 | Odonate Therapeutics, Inc. (ODT) Delisted | Grant (A) | +22 | $542 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.